Production (Stage)
QIAGEN N.V.
QGEN
$42.05
-$0.27-0.64%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 483.46M | 521.20M | 501.87M | 496.35M | 458.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 483.46M | 521.20M | 501.87M | 496.35M | 458.80M |
| Cost of Revenue | 161.29M | 171.09M | 171.24M | 446.37M | 151.73M |
| Gross Profit | 322.16M | 350.11M | 330.63M | 49.98M | 307.06M |
| SG&A Expenses | 137.94M | 141.71M | 140.66M | 143.30M | 138.69M |
| Depreciation & Amortization | 15.27M | 15.32M | 16.10M | 17.93M | 18.80M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 358.29M | 376.73M | 372.44M | 656.70M | 360.55M |
| Operating Income | 125.16M | 144.48M | 129.43M | -160.36M | 98.25M |
| Income Before Tax | 119.55M | 125.85M | 116.46M | -223.45M | 102.29M |
| Income Tax Expenses | 28.79M | 37.53M | 18.40M | -39.99M | 21.62M |
| Earnings from Continuing Operations | 90.76M | 88.32M | 98.06M | -183.46M | 80.67M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 90.76M | 88.32M | 98.06M | -183.46M | 80.67M |
| EBIT | 125.16M | 144.48M | 129.43M | -160.36M | 98.25M |
| EBITDA | 169.07M | 177.03M | 179.42M | -106.96M | 152.58M |
| EPS Basic | 0.42 | 0.41 | 0.45 | -0.85 | 0.37 |
| Normalized Basic EPS | 0.38 | 0.44 | 0.39 | -0.45 | 0.30 |
| EPS Diluted | 0.41 | 0.40 | 0.45 | -0.85 | 0.37 |
| Normalized Diluted EPS | 0.37 | 0.44 | 0.38 | -0.45 | 0.30 |
| Average Basic Shares Outstanding | 218.38M | 218.02M | 216.14M | 215.82M | 217.62M |
| Average Diluted Shares Outstanding | 220.19M | 218.02M | 217.81M | 215.82M | 220.28M |
| Dividend Per Share | 0.25 | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |